CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,027 | -37.6% | 521,251 | -2.1% | 0.00% | – |
| Q2 2023 | $1,219,152 | +171.6% | 532,381 | +7.9% | 0.00% | – |
| Q1 2023 | $448,832 | +7.6% | 493,222 | +0.5% | 0.00% | – |
| Q4 2022 | $417,164 | +1.5% | 490,781 | -2.4% | 0.00% | – |
| Q3 2022 | $411,000 | -18.0% | 502,942 | -0.5% | 0.00% | – |
| Q2 2022 | $501,000 | -38.8% | 505,566 | +1.2% | 0.00% | – |
| Q1 2022 | $819,000 | -33.0% | 499,474 | -1.5% | 0.00% | – |
| Q4 2021 | $1,223,000 | +151.6% | 507,272 | +405.0% | 0.00% | – |
| Q3 2021 | $486,000 | +38.9% | 100,451 | -23.3% | 0.00% | – |
| Q2 2021 | $350,000 | +46.4% | 130,928 | +68.6% | 0.00% | – |
| Q1 2021 | $239,000 | -3.6% | 77,668 | +11.3% | 0.00% | – |
| Q4 2020 | $248,000 | -61.7% | 69,810 | -56.8% | 0.00% | – |
| Q3 2020 | $647,000 | -23.3% | 161,549 | -48.0% | 0.00% | – |
| Q2 2020 | $844,000 | +27.1% | 310,482 | -1.5% | 0.00% | – |
| Q1 2020 | $664,000 | -61.1% | 315,277 | +0.5% | 0.00% | – |
| Q4 2019 | $1,707,000 | +69.7% | 313,837 | -6.1% | 0.00% | – |
| Q3 2019 | $1,006,000 | -19.1% | 334,096 | +0.3% | 0.00% | – |
| Q2 2019 | $1,244,000 | -66.4% | 332,934 | -63.9% | 0.00% | – |
| Q1 2019 | $3,707,000 | +6.7% | 921,960 | -2.6% | 0.00% | – |
| Q4 2018 | $3,473,000 | -66.4% | 946,378 | -21.6% | 0.00% | – |
| Q3 2018 | $10,350,000 | -15.8% | 1,206,520 | +7.8% | 0.00% | -100.0% |
| Q2 2018 | $12,290,000 | +44.6% | 1,119,507 | +51.9% | 0.00% | – |
| Q1 2018 | $8,499,000 | +22.5% | 737,118 | +10.1% | 0.00% | – |
| Q4 2017 | $6,937,000 | +14.3% | 669,657 | +76.0% | 0.00% | – |
| Q3 2017 | $6,067,000 | +35.8% | 380,561 | +3.1% | 0.00% | – |
| Q2 2017 | $4,468,000 | +20.5% | 369,202 | +106.7% | 0.00% | – |
| Q1 2017 | $3,709,000 | +123533.3% | 178,618 | +74949.6% | 0.00% | – |
| Q4 2016 | $3,000 | -57.1% | 238 | -45.7% | 0.00% | – |
| Q3 2016 | $7,000 | +133.3% | 438 | +119.0% | 0.00% | – |
| Q2 2016 | $3,000 | -98.3% | 200 | -98.3% | 0.00% | – |
| Q1 2016 | $174,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |